宫颈癌地理负担分析器:用于理解复发或转移性宫颈癌患者地理疾病负担的交互式开放获取工具
该研究基于2015—2020年MarketScan商业与补充医保索赔数据,对410个大都市统计区(MSA)进行回顾性分析,以接受复发或转移性宫颈癌(r/mCC)全身治疗的患者数占宫颈癌诊断患者数的比例估计r/mCC负担。研究开发了公开的网页工具Cervical Cancer Geo-Analyzer,可跨MSA、跨年度可视化r/mCC负担。结果显示MSA间负担差异大(范围0—83.3%),部分地区上升、部分地区下降,且存在数据稀疏或缺失区域。
要点
- r/mCC负担以接受全身治疗患者数占宫颈癌诊断患者数的比例估计,MSA间范围0—83.3%。
- 波士顿-剑桥-牛顿MA的r/mCC与CC比值从2018年41%升至2020年50%。
- 大急流城MI的r/mCC负担从2018年55%降至2020年31%。
核心结论
- Cervical Geo-Analyzer是可可视化宫颈癌干预高需求区域的工具,并为理解局部疾病负担风险因素、识别关注人群、刻画宫颈癌或r/mCC健康差异及指导针对性干预奠定基础。
研究设计与样本
- 回顾性分析2015—2020年MarketScan商业与补充医保索赔数据,覆盖410个大都市统计区(MSA)。
- r/mCC负担估计为每个MSA中接受r/mCC全身治疗的患者数除以宫颈癌诊断患者数。
- 开发了公开的网页工具Cervical Cancer Geo-Analyzer(http://www.geo-analyzer.org),支持跨MSA、跨年度可视化r/mCC负担。
主要发现
- MSA间r/mCC负担差异大,范围为0—83.3%。
- 波士顿-剑桥-牛顿MA的r/mCC与CC比值从2018年41%升至2020年50%。
- 萨克拉门托-罗斯维尔-阿登-阿卡德CA的r/mCC与CC比值从2018年33%升至2020年50%。
- 大急流城MI的r/mCC负担从2018年55%降至2020年31%。
- 旧金山-奥克兰-海沃德CA的r/mCC负担从2018年40%降至2020年26%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 存在数据稀疏或缺失的区域,提示需要更具代表性的数据捕获。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Cervical cancer (CC) disproportionately affects women based on socioeconomic status and racial/ethnic background. There is limited research in quantifying and visualizing whether substantial geographical disparities in the US exist with respect to CC burden, and especially with respect to recurrent or metastatic CC (r/mCC) disease burden. Identifying regions with higher r/mCC burden may help inform effective healthcare resource allocation and navigating patients to appropriate care. METHODS: We conducted a retrospective analysis of the 2015-2020 MarketScan® Commercial and Supplemental Medicare claims data; r/mCC burden was estimated as the number of patients initiating r/mCC systemic therapy over CC-diagnosed patients for each of the 410 metropolitan statistical areas (MSAs) considered. We developed a public, web-based tool, the Cervical Cancer Geographical Disease Burden Analyzer (Cervical Cancer Geo-Analyzer, http://www.geo-analyzer.org), that allows users to visualize r/mCC burden across MSAs over multiple years. RESULTS: There was considerable variation in r/mCC burden across MSAs, with a range of 0-83.3%. Burden increased in Boston-Cambridge-Newton, MA (r/mCC to CC ratio: 41% in 2018 to 50% in 2020), and Sacramento-Roseville-Arden-Arcade, CA (33% in 2018 to 50% in 2020). On the other hand, while r/mCC burden remained high, it decreased in Grand Rapids, MI (55% in 2018 to 31% in 2020) and San Francisco-Oakland-Hayward, CA (40% in 2018 to 26% in 2020). There were regions with sparse or no data, suggesting a need for more representative data capture. CONCLUSION: The Cervical Geo-Analyzer is a tool to visualize areas with high need for CC interventions. It also builds the foundation for further work to understand local risk factors of disease burden, identify populations of interest, characterize health disparities of CC or r/mCC and inform targeted interventions.
引用
- Castellano T, Moore K, Ting J, et al. Cervical cancer geographical burden analyzer: An interactive, open-access tool for understanding geographical disease burden in patients with recurrent or metastatic cervical cancer. Gynecol Oncol. 2022. PMID: 36549175. doi:10.1016/j.ygyno.2022.12.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。